NeoGenomics (NEO)
(Delayed Data from NSDQ)
$14.78 USD
-0.13 (-0.87%)
Updated May 21, 2024 04:00 PM ET
After-Market: $14.77 -0.01 (-0.07%) 5:00 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Brokerage Reports
NeoGenomics, Inc. [NEO]
Reports for Purchase
Showing records 121 - 132 ( 132 total )
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Raises 2Q 2014 Revenue Guidance by 5.2%
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Not content to rest on its past history of growth
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Initiation of Coverage
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G